Log in
Show password
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Dynamic quotes 
  1. Homepage
  2. Equities
  3. France
  4. Euronext Paris
  5. Rubis
  6. News
  7. MarketScreener Strategies
    RUI   FR0013269123


SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Rubis : Very little upside potential, so the risk for a correction is significant

03/31/2021 | 02:52am EDT
short sell
Target price hit
Entry price : 40.98€ | Target : 38€ | Stop-loss : 43.5€ | Potential : 7.27%
The price of shares in Rubis is close to a major medium term resistance level around 41.5 EUR. A correction phase over the short term appears to be the logical outcome.
Investors should open a short trade and target the € 38.
Rubis : Rubis : Very little upside potential, so the risk for a correction is significant
  • There is high visibility into the group's activities for the coming years. Outlooks on future revenues from analysts covering the equity remain similar. Such hardly dispersed estimates support highly predictable sales for the current and upcoming fiscal years.
  • The company has attractive valuation levels with a low EV/sales ratio compared with its peers.
  • The company is one of the best yield companies with high dividend expectations.
  • Over the last 4 months, analysts have significantly revised upwards the company's estimated sales.
  • Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
  • The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.

  • Technically, the stock approaches a strong medium-term resistance at EUR 41.5.
  • As estimated by analysts, this group is among those businesses with the lowest growth prospects.
  • For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
  • For the last four months, EPS estimates made by Standard & Poor's analysts have been revised downwards.

© MarketScreener.com 2021

Disclaimer: The information, charts, data, views, or comments provided by SURPERFORMANCE SAS are intended for investors who have the necessary knowledge and experience to understand and appreciate the information contained within. These items are disseminated for personal reference only. They do not constitute an offer or solicitation to buy or sell financial products or services, nor an investment advice.
The use of the information disseminated takes place under the investor's sole responsibility, without recourse against SURPERFORMANCE SAS. SURPERFORMANCE SAS will not be liable, whether in contract, in tort, under any warranty, for errors, omissions, improper investments, or adverse evolution of markets.

Sales 2021 4 239 M 4 953 M 4 953 M
Net income 2021 284 M 332 M 332 M
Net Debt 2021 458 M 535 M 535 M
P/E ratio 2021 10,3x
Yield 2021 6,58%
Capitalization 2 883 M 3 341 M 3 369 M
EV / Sales 2021 0,79x
EV / Sales 2022 0,73x
Nbr of Employees 4 123
Free-Float 85,1%
Upcoming event on RUBIS
Income Statement Evolution
Mean consensus OUTPERFORM
Number of Analysts 6
Last Close Price 28,15 €
Average target price 45,48 €
Spread / Average Target 61,6%
EPS Revisions
Managers and Directors
Bruno Krief Chief Financial Officer
Olivier Heckenroth Chairman-Supervisory Board
Chantal Mazzacurati Member-Supervisory Board
Laure Grimonpret-Tahon Member-Supervisory Board
Marie-Hélène Dessailly Member-Supervisory Board
Sector and Competitors